Based on our advanced algorithm, we predict that DAWN stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $6.62, while the 1-week outlook suggests a value of $6.59. For the 1-month forecast, we project a price of $6.44. Looking further ahead, our 2026 projection estimates a value of $0.00, with a long-term 2030 forecast reaching $0.00. Stay informed and make strategic decisions with our data-driven insights!
Should I Buy Day One Biopharmaceuticals Inc Stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. DAWN has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
DAWN stock price ended at $6.62 on Thursday, after rising0%
The Day One Biopharmaceuticals Inc stock price increased by 0% on the last trading day (17 Jul 2025), rising from 6.63 to 6.62. Throughout the last trading session, the stock experienced a fluctuation of 3.30% , ranging from a day low of $6.515 to a day high of 6.73. The price has declined in 4 of the last 10 days, resulting in a total change of 0.15% during this period. On the last day, trading volume decrease by -138.32K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 1.55M shares were traded, amounting to approximately 10.25M.
DAWN Technical Signals
DAWN(Day One Biopharmaceuticals Inc Corp) has 3 buy signals and 0 sell signals now. The current trend is downtrend starting from 2025-06-03. The total price change during this trend is -5.16%. Recently, the price has increased but the volume has decreased, indicating a potential warning signal. The average turnover of DAWN over the last 5 trading days is 9.45M. Overall, the technical indicator signals lean more toward a Bullish outlook in the mid-term.
DAWN Moving Average Analysis
Day One Biopharmaceuticals Inc's overall moving average trend leans more bearish as of Thursday, July 17, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $7.30, and $7.57. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $6.40, and $6.12. A break-down below any of these levels will issue sell signals.
DAWN Short Selling Analysis
The short sale ratio of Day One Biopharmaceuticals Inc(DAWN) as of 15 Jul 2025 is 26.72%, rising from last trading day. With increasing price from 6.79 to 6.57. The short sell activity indicate that short sellers may be anticipating further declines.
Technical Signal
Technical Signals Summary
Sell
0
Buy
3
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Positive
SMA_60 Above SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
3 Bullish Signals
3 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
0.161
Bullish
Momentum (10 days)
MOM_10 > 0
0.01
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.0188
Bullish
0 Bearish Signals
0 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
In 2026, Day One Biopharmaceuticals Inc (DAWN) is anticipated to change hands in a trading channel between $0.00 and $0.00.
Day One Biopharmaceuticals Inc Stock Forecast 2026
DAWN Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Day One Biopharmaceuticals Inc(DAWN), our algorithm predicts DAWN's 1-month price at $6.56, with an -3.33%downwardshift. Using a similarity score up to 92.21%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Day One Biopharmaceuticals Inc (DAWN.O) stock, as of Sunday, July 13, 2025 , forecasts a -3.33% change over the next month, based on its high correlation with BVFL.O stock patterns. The similarity between their price movements over the analyzed periods is 92.21%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
DAWN
No Data
BVFL
Down: -3.33%Similarity: 92.21%
Name
Similarity
Up/Down
BVFL.O
92.21%
-3.33%
ASRT.O
90.50%
+13.16%
DAWN Seasonality Analysis
Based on DAWN's historical stock price data across all years, the probability of a positive return in July is80.00%, suggesting it maybe an ideal month to invest in DAWN. In contrast,Julyoffers the highest probability of positive returns at80.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Day One Biopharmaceuticals Inc (DAWN.O) stock in July has the highest probability of a positive return (80.00%), while March has the lowest probability (0.00%).
Performance Seasonality
The chart shows Day One Biopharmaceuticals Inc. (DAWN)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Day One Biopharmaceuticals Inc (DAWN.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. DAWN has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying Day One Biopharmaceuticals Inc (DAWN.O) stock in a year?
The radar chart shows that buying Day One Biopharmaceuticals Inc (DAWN.O) stock in July has the highest probability of a positive return (80.00%), while March has the lowest probability (0.00%).
How has Day One Biopharmaceuticals Inc. (DAWN)'s stock price performed over the past three years?
DAWN's stock price fell by -27.90% in 2023,decreased by -12.74% in 2024, and went down by 47.92%in 2025.
Which bull technical signals does DAWN have?
Bullish technical signals of DAWN include: AO_5_34 > 0, MOM_10 > 0, MACD_12_26_9 > 0.
Which bearish technical signals does DAWN have?
Bearish technical signals of DAWN include:
Is DAWN a buy based on overall technical signals summary?
DAWN has 3 buy signals and 0 sell signals now. Overall the technical rating for DAWN is Buy . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of DAWN.
What is the trend of Day One Biopharmaceuticals Inc (DAWN)'s moving average?
Day One Biopharmaceuticals Inc's overall moving average trend leans more bearish as of July 17 2025, with 3 negative signals and 1 positive signal.
What is price prediction for DAWN stock next month?
The price prediction chart for Day One Biopharmaceuticals Inc (DAWN.O) stock, as of July 13 2025, forecasts a -3.33% change over the next month, based on its high correlation with BVFL stock patterns. The similarity between their price movements over the analyzed periods is 92.21%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for DAWN Stock?
DAWN stock is predicted to reach a price target of **$29.00** by 2025, representing a **265.70% upside** from its current price of $7.93, driven by favorable analyst consensus and strong growth prospects. The stock's technical indicators, such as the RSI and MACD, suggest potential upside, while the company's Zacks Rank #1 (Strong Buy) further supports its bullish outlook. However, risks include declining revenue estimates and earnings misses, which could impact the stock's performance.
What is price prediction 2030 for DAWN Stock?
DAWN stock is predicted to reach approximately **$30 by 2030**, driven by its strong pipeline and growth in the biopharmaceutical sector. Analysts expect significant revenue growth and successful drug developments to fuel this increase.